ACRX - 2.25 Pre-market now at 240/2.50 AcelRx Announces Completion of the Human Factors Study for DSUVIA and Confirms Plans to Resubmit NDA in Q2 2018 http://stockcharts.com/c-sc/sc?s=ACRX&p=D&b=5&g=0&i=t76250924011&r=1523879591439